Snowball logo
logo
XVIP_logo

Xvivo Perfusion AB (publ)

XVIPF β€’ PINK
$21.68-$0.12Β  (0.55%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
2,337.6415.3597.5822.4810.1942.5
COGS
634.2118.3152.4206278328.1
Gross Profit
1,703.3297445.1616.4532.2614.4
Operating Expenses & Income
Operating Income
(167.3)6.4094.18788.3592.78115.1
Total Operating Expenses
1,872.9292.5440.9528.1439.4499.4
R&D Expenses
488.969.34135.9148.3100.4118.6
Selling General & Admin Expenses
503.870.9876.9495.7978.14159.6
Earnings from Continuing Operations
Interest Expense
(2.496917)(0.605)(1.19)(61.78)(44.26)-
Interest Income
-2.1238.8517.167.877-
Income Tax Expense
(13.45)3.8872.70127.7713.3626.9
Net Income
Net Income
73.7518.4391.82172.225.1126.2
Supplemental
EBIT
62.7922.924.187201.282.72119.1
EBITDA
354.665.0980.54288.9152.8198.4
In millions of USD, except % and values per 1 share